Top

European Journal of Medical Research

Published in:

Open Access 01-12-2023 | Pre-Eclampsia | Research

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia

Authors: Xinwen Chang, Qizhi He, Mengtian Wei, Linyan Jia, Yingying Wei, Yiding Bian, Tao Duan, Kai Wang

Published in: European Journal of Medical Research | Issue 1/2023

Abstract

Background

Preeclampsia is a unique multisystem disorder that affects 5–8% of pregnancies. A high level of soluble fms-like tyrosine kinase-1 (sFlt-1) is a hallmark of preeclampsia that causes endothelial dysfunction. Exosomes derived from mesenchymal stem cells (MSCs) have been indicated to improve endothelial performances by transporting signals to target cells. We hypothesized that exosomes derived from MSCs have potential effects against preeclampsia.

Methods

We collected human umbilical cord MSC-derived exosomes (HUCMSC-exos) by ultracentrifugation. The size and morphology of the exosomes were examined using a transmission electron microscope and nanoparticle tracking analysis. Pregnant mice were injected with murine sFlt-1 adenovirus to build the preeclampsia-like mouse model and then treated with HUCMSC-exos. Human umbilical vein endothelial cells (HUVECs) were infected with lentiviruses expressing tet-on-sFlt-1 to obtain cells overexpressing sFlt-1. Cell proliferation and migration assays were used to measure the endothelial functions. The exosomes enriched proteins underlying mechanisms were explored by proteomic analysis.

Results

In the current study, we successfully collected the cup-shaped HUCMSC-exos with diameters of 30–150 nm. In the sFlt-1-induced preeclampsia mouse model, HUCMSC-exos exhibited beneficial effects on adverse birth events by decreasing blood pressure and improving fetal birth weight. In addition, preeclamptic dams that were injected with HUCMSC-exos had rebuilt dense placental vascular networks. Furthermore, we observed that HUCMSC-exos partially rescued sFlt-1-induced HUVECs dysfunction in vitro. Proteomics analysis of HUCMSC-exos displayed functional enrichment in biological processes related to vesicle-mediated transport, cell communication, cell migration, and angiogenesis.

Conclusion

We propose that exosomes derived from HUCMSCs contain abundant Versican and play beneficial roles in the birth outcomes of sFlt-1-induced preeclamptic mice by promoting angiogenesis.

Graphical Abstract

Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–4. https://doi.org/10.1126/science.1111726.CrossRefPubMed

Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013;381(9879):1747–55. https://doi.org/10.1016/s0140-6736(13)60686-8.CrossRefPubMed

Stepan H, Geide A, Faber R. Soluble fms-like tyrosine kinase 1. New England J Med. 2004;351(21):2241–2. https://doi.org/10.1056/nejm200411183512123.CrossRef

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. New England J Med. 2004;350(7):672–83. https://doi.org/10.1056/NEJMoa031884.CrossRef

Yang W, Zhang J, Xu B, He Y, Liu W, Li J, et al. HucMSC-derived exosomes mitigate the age-related retardation of fertility in female mice. Mol Ther. 2020;28(4):1200–13. https://doi.org/10.1016/j.ymthe.2020.02.003.CrossRefPubMedPubMedCentral

Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, et al. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. Biomaterials. 2018;174:67–78. https://doi.org/10.1016/j.biomaterials.2018.04.055.CrossRefPubMed

Shareghi-Oskoue O, Aghebati-Maleki L, Yousefi M. Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther. 2021;12(1):454. https://doi.org/10.1186/s13287-021-02529-w.CrossRefPubMedPubMedCentral

Huang Y, Wu Y, Chang X, Li Y, Wang K, Duan T. Effects of human umbilical cord mesenchymal stem cells on human trophoblast cell functions in vitro. Stem Cells Int. 2016;2016:9156731. https://doi.org/10.1155/2016/9156731.CrossRefPubMedPubMedCentral

Ruivo CF, Sugimoto H, Lee JJ, Kalluri R, Melo SA, Yang S, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503.CrossRefPubMedPubMedCentral

10.

Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell. 2019;177(2):428–45. https://doi.org/10.1016/j.cell.2019.02.029.CrossRefPubMedPubMedCentral

11.

Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https://doi.org/10.1126/science.aau6977.CrossRefPubMedPubMedCentral

12.

Chang X, Yao J, He Q, Liu M, Duan T, Wang K. Exosomes from women with preeclampsia induced vascular dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to endothelial cells. Hypertension. 2018;72(6):1381–90. https://doi.org/10.1161/hypertensionaha.118.11706.CrossRefPubMed

13.

Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, et al. Pre-eclampsia. Nat Rev Dis Primers. 2023;9(1):8. https://doi.org/10.1038/s41572-023-00417-6.CrossRefPubMed

14.

Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC State-of-the-Art review. J Am Coll Cardiol. 2020;76(14):1690–702. https://doi.org/10.1016/j.jacc.2020.08.014.CrossRefPubMed

15.

Lei Q, Gao F, Liu T, Ren W, Chen L, Cao Y, et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow-derived mesenchymal stem cells and slow age-related degeneration. Sci Transl Med. 2021. https://doi.org/10.1126/scitranslmed.aaz8697.CrossRefPubMed

16.

Eirin A, Zhu XY, Jonnada S, Lerman A, van Wijnen AJ, Lerman LO. Mesenchymal stem cell-derived extracellular vesicles improve the renal microvasculature in metabolic renovascular disease in Swine. Cell Transpl. 2018;27(7):1080–95. https://doi.org/10.1177/0963689718780942.CrossRef

17.

Li X, Liu LL, Yao JL, Wang K, Ai H. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles inhibit endometrial cancer cell proliferation and migration through delivery of exogenous miR-302a. Stem Cells Int. 2019. https://doi.org/10.1155/2019/8108576.CrossRefPubMedPubMedCentral

18.

Zhilai Z, Biling M, Sujun Q, Chao D, Benchao S, Shuai H, et al. Preconditioning in lowered oxygen enhances the therapeutic potential of human umbilical mesenchymal stem cells in a rat model of spinal cord injury. Brain Res. 2016;1642:426–35. https://doi.org/10.1016/j.brainres.2016.04.025.CrossRefPubMed

19.

Burke SD, Zsengellér ZK, Khankin EV, Lo AS, Rajakumar A, DuPont JJ, et al. Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. J Clin Investig. 2016;126(7):2561–74. https://doi.org/10.1172/jci83918.CrossRefPubMedPubMedCentral

20.

Chang X, Bian Y, He Q, Yao J, Zhu J, Wu J, et al. Suppression of STAT3 signaling by Delta9-tetrahydrocannabinol (THC) induces trophoblast dysfunction. Cell Physiol Biochem. 2017;42(2):537–50. https://doi.org/10.1159/000477603.CrossRefPubMed

21.

Li Y, Zhao YJ, Zou QY, Zhang K, Wu YM, Zhou C, et al. Preeclampsia does not alter vascular growth and expression of CD31 and vascular endothelial cadherin in human placentas. J Histochem Cytochem. 2015;63(1):22–31. https://doi.org/10.1369/0022155414558063.CrossRefPubMedPubMedCentral

22.

Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25(4):501–15. https://doi.org/10.1016/j.ccr.2014.03.007.CrossRefPubMedPubMedCentral

23.

Chang X, Li H, Li Y, He Q, Yao J, Duan T, et al. RhoA/MLC signaling pathway is involved in Delta(9)-tetrahydrocannabinol-impaired placental angiogenesis. Toxicol lett. 2018;285:148–55. https://doi.org/10.1016/j.toxlet.2017.12.031.CrossRefPubMed

24.

Ahn TG, Hwang JY. Preeclampsia and aspirin. Obstet Gynecol Sci. 2023. https://doi.org/10.5468/ogs.22261.CrossRefPubMedPubMedCentral

25.

Rezaie J, Feghhi M, Etemadi T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal. 2022;20(1):145. https://doi.org/10.1186/s12964-022-00959-4.CrossRefPubMedPubMedCentral

26.

Colao IL, Corteling R, Bracewell D, Wall I. Manufacturing exosomes: a promising therapeutic platform. Trends Mol Med. 2018;24(3):242–56. https://doi.org/10.1016/j.molmed.2018.01.006.CrossRefPubMed

27.

Xiong ZH, Wei J, Lu MQ, Jin MY, Geng HL. Protective effect of human umbilical cord mesenchymal stem cell exosomes on preserving the morphology and angiogenesis of placenta in rats with preeclampsia. Biomed Pharmacother. 2018;105:1240–7. https://doi.org/10.1016/j.biopha.2018.06.032.CrossRefPubMed

28.

Sun X, Mao Y, Liu B, Gu K, Liu H, Du W, et al. Mesenchymal stem cell-derived exosomes enhance 3D-printed scaffold functions and promote alveolar bone defect repair by enhancing angiogenesis. J Pers Med. 2023. https://doi.org/10.3390/jpm13020180.CrossRefPubMedPubMedCentral

29.

Wu D, Qin H, Wang Z, Yu M, Liu Z, Peng H, et al. Bone mesenchymal stem cell-derived sEV-Encapsulated thermosensitive hydrogels accelerate osteogenesis and angiogenesis by release of exosomal miR-21. Front Bioeng Biotechnol. 2021;9:829136. https://doi.org/10.3389/fbioe.2021.829136.CrossRefPubMed

30.

Jena MK, Sharma NR, Petitt M, Maulik D, Nayak NR. Pathogenesis of preeclampsia and therapeutic approaches targeting the Placenta. Biomolecules. 2020. https://doi.org/10.3390/biom10060953.CrossRefPubMedPubMedCentral

31.

Rai A, Cross JC. Development of the hemochorial maternal vascular spaces in the placenta through endothelial and vasculogenic mimicry. Dev Biol. 2014;387(2):131–41. https://doi.org/10.1016/j.ydbio.2014.01.015.CrossRefPubMed

32.

Nezu M, Souma T, Yu L, Sekine H, Takahashi N, Wei AZ, et al. Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes. Sci Signaling. 2017;10(479):5711.CrossRef

33.

Hermann M, Flammer A, Lüscher TF. Nitric oxide in hypertension. J Clin Hypertens. 2006;8(12):17–29. https://doi.org/10.1111/j.1524-6175.2006.06032.x.CrossRef

34.

Yang B, Chen Y, Shi J. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms. Adv Mater. 2019;31(2):e1802896. https://doi.org/10.1002/adma.201802896.CrossRefPubMed

35.

Zheng Y, Li M, Weng B, Mao H, Zhao J. Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer. Biomater Sci. 2022;10(7):1607–25. https://doi.org/10.1039/d2bm00062h.CrossRefPubMed

36.

Liu H, Wang F, Zhang Y, Xing Y, Wang Q. Exosomal microRNA-139–5p from mesenchymal stem cells accelerates trophoblast cell invasion and migration by motivation of the ERK/MMP-2 pathway via downregulation of protein tyrosine phosphatase. J Obstet Gynaecol Res. 2020;46(12):2561–72. https://doi.org/10.1111/jog.14495.CrossRefPubMedPubMedCentral

37.

Tang H, He Y, Li L, Mao W, Chen X, Ni H, et al. Exosomal MMP2 derived from mature osteoblasts promotes angiogenesis of endothelial cells via VEGF/Erk1/2 signaling pathway. Exp Cell Res. 2019;383(2):111541. https://doi.org/10.1016/j.yexcr.2019.111541.CrossRefPubMed

38.

Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, et al. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. Faseb j. 2004;18(6):754–6. https://doi.org/10.1096/fj.03-0545fje.CrossRefPubMed

39.

Nandadasa S, O’Donnell A, Murao A, Yamaguchi Y, Midura RJ, Olson L, et al. The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1(+) hematoendothelial progenitors. Matrix Biol. 2021. https://doi.org/10.1016/j.matbio.2021.01.002.CrossRefPubMedPubMedCentral

Title: Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
Authors: Xinwen Chang
Qizhi He
Mengtian Wei
Linyan Jia
Yingying Wei
Yiding Bian
Tao Duan
Kai Wang
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Pre-Eclampsia
Adenovirus
Published in: European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI: https://doi.org/10.1186/s40001-023-01182-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia

Abstract

Background

Methods

Results

Conclusion

Graphical Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Graphical Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

French recommendations for the management of glycogen storage disease type III

Efficacy of minimally invasive tubular approaches for management of the lumbar spinal synovial cysts: a meta-analysis

Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin

siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy

Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on 18F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine

Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication